Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 135 of 641 · 7,691 filings

  • ADC Therapeutics (ADCT) FY2025 10-K risk factors
    58 risks6 new2 dropped14 reworded

    New trade tariffs and FDA employment reductions introduce external headwinds to manufacturing and regulatory approvals. The HCR Agreement now imposes a $150 million to $200 million change in control fee. Swiss tax loss carryforwards decreased from $1,059 million to $1,009 million.

    Filed Mar 10, 2026
  • Apyx Medical (APYX) FY2025 10-K risk factors
    29 risks3 reworded

    Equity dilution figures were updated to reflect lower option and warrant percentages as of December 31, 2025. Macroeconomic risk discussion was updated to incorporate the Federal Reserve's rate cuts in late 2024 and 2025. Consumer demand risk now highlights GLP-1 drugs as a factor affecting discretionary spending and procedure timing.

    Filed Mar 10, 2026
  • Arq (ARQ) FY2025 10-K risk factors
    40 risks11 new11 dropped20 reworded

    Arq faces severe capital constraints, construction delays, and design flaws at its GAC facility, leading to a $44.8 million impairment.

    Filed Mar 10, 2026
  • Artiva Biotherapeutics (ARTV) FY2025 10-K risk factors
    103 risks11 new2 dropped13 reworded

    Artiva Biotherapeutics highlights a cash runway of $108.0 million into the second quarter of 2027, rising net losses, and new legislative and trade policy hurdles.

    Filed Mar 10, 2026
  • AerSale (ASLE) FY2025 10-K risk factors
    42 risks1 new3 reworded

    AerSale added lessee repossession hurdles and updated international conflict and warehouse fire disclosures. Asset recovery and international stability remain core risks.

    Filed Mar 10, 2026
  • Backblaze (BLZE) FY2025 10-K risk factors
    55 risks5 new4 dropped23 reworded

    Backblaze is managing headcount reductions while expanding its focus on AI model builders and neocloud partners. The company faces new operational constraints from a $20 million credit facility and potential short seller manipulation. Tax legislation like the OBBB Act will affect net operating losses.

    Filed Mar 10, 2026
  • Beachbody (BODI) FY2025 10-K risk factors
    81 risks4 new4 dropped13 reworded

    The company replaced its credit facility, shifting debt maturities and financial covenants to an ABL Facility maturing May 13, 2028. Operations face new risks from entering the retail market with Shakeology and deploying artificial intelligence technologies. Partner and preferred customer fee streams ceased following a strategic Pivot.

    Filed Mar 10, 2026
  • CoinShares Bitcoin ETF (BRRR) FY2025 10-K risk factors
    99 risks

    The Trust is entirely exposed to bitcoin, whose price, liquidity and market structure can be highly volatile.

    Filed Mar 10, 2026
  • Cadre Holdings (CDRE) FY2025 10-K risk factors
    49 risks3 new3 dropped10 reworded

    Cadre Holdings added disclosures regarding risks from emerging AI tools, rising minimum wages, and the expiration of its emerging growth company status. The company removed specific references to the Russia-Ukraine and Israel-Palestine military conflicts from its energy risk factor.

    Filed Mar 10, 2026
  • Cullinan Therapeutics (CGEM) FY2025 10-K risk factors
    94 risks5 new2 dropped17 reworded

    Cullinan updated its risk profile to reflect its return to smaller reporting company status and the adoption of AI regulations.

    Filed Mar 10, 2026
  • Creative Media & Community Trust (CMCT) FY2025 10-K risk factors
    101 risks2 new16 dropped13 reworded

    Tenant concentration and California market risks threaten cash flows and preferred stock distributions.

    Filed Mar 10, 2026
  • Core Molding Technologies (CMT) FY2025 10-K risk factors
    30 risks5 new2 dropped5 reworded

    Customer concentration fell slightly with five customers generating 65% of 2025 sales.

    Filed Mar 10, 2026

Companies covered

4,011 companies

371 more under A